These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31989466)

  • 1. Full report on a survey of adverse reactions to radiopharmaceuticals from 1975 to 2017 in Japan.
    Matsuda H; Uehara T; Okazawa H; Mizumura S; Yokoyama K; Yoshimura M;
    Ann Nucl Med; 2020 Apr; 34(4):299-304. PubMed ID: 31989466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database.
    Laroche ML; Quelven I; Mazère J; Merle L
    Ann Pharmacother; 2015 Jan; 49(1):39-47. PubMed ID: 25366341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The 41st Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 44th Survey in 2018)].
    ; Matsuda H; Uehara T; Okazawa H; Mizumura S; Yokoyama K; Yoshimura M
    Kaku Igaku; 2020; 57(1):11-21. PubMed ID: 32074551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Radiopharmaceutical Adverse Reaction Reports to the British Nuclear Medicine Society from 2007 to 2016.
    Kennedy-Dixon TG; Gossell-Williams M; Cooper M; Trabelsi M; Vinjamuri S
    J Nucl Med; 2017 Dec; 58(12):2010-2012. PubMed ID: 28522742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The 42nd Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 45th Survey in 2019)].
    ; Okazawa H; Uehara T; Kuji I; Higashi T; Yoshimura M
    Kaku Igaku; 2021; 58(1):1-11. PubMed ID: 33612568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The 45th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 48th Survey in 2022)].
    ; Okazawa H; Uehara T; Kuji I; Higashi T; Yoshimura M
    Kaku Igaku; 2024; 61(1):1-12. PubMed ID: 38382921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The 44th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 47th Survey in 2021)].
    ; Okazawa H; Uehara T; Kuji I; Higashi T; Yoshimura M
    Kaku Igaku; 2023; 60(1):1-12. PubMed ID: 36792223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The 43rd Report on the Survey of Adverse Reactions to Radiopharmaceuticals (46th Survey in 2020)].
    ; Okazawa H; Uehara T; Kuji I; Higashi T; Yoshimura M
    Kaku Igaku; 2022; 59(1):1-12. PubMed ID: 35321966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The 34th report on survey of the adverse reaction to radiopharmaceuticals (the 37th Survey in 2011)].
    Matsuda H; Arano Y; Okazawa H; Mizumura S; Yokoyama K; Yoshimura M; ; ;
    Kaku Igaku; 2013 Feb; 50(1):13-25. PubMed ID: 23700820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The 36th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 39th Survey in 2013)].
    Matsuda H; Arano Y; Okazawa H; Mizumura S; Yokoyama K; Yoshimura M
    Kaku Igaku; 2015 Feb; 52(1):1-12. PubMed ID: 26502668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The 35th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 38th Survey in 2012)].
    Matsuda H; Arano Y; Okazawa H; Mizumura S; Yokoyama K; Yoshimura M; ;
    Kaku Igaku; 2014 Feb; 51(1):1-12. PubMed ID: 24765821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of adverse reactions to positron emitting radiopharmaceuticals in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine.
    Silberstein EB
    J Nucl Med; 1998 Dec; 39(12):2190-2. PubMed ID: 9867168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The 30th report on survey of the adverse reaction to radiopharmaceuticals (the 33rd survey in 2007)].
    Matsuda H; Arano Y; Okazawa H; Okamura T; Mizumura S; Yokoyama K; ;
    Kaku Igaku; 2009 Mar; 46(1):29-41. PubMed ID: 19413193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The 27th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 30th survey in 2004)].
    Kusakabe K; Okamura T; Kasagi K; Komatani A; Sato Y; Matsuda H; Maruno H; ;
    Kaku Igaku; 2006 Feb; 43(1):23-35. PubMed ID: 16634540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The 29th report on survey of the adverse reaction to radiopharmaceuticals (the 32nd survey in 2006)].
    Kusakabe K; Arano Y; Okamura T; Kasagi K; Komatani A; Matsuda H; Maruno H; ; ;
    Kaku Igaku; 2008 Feb; 45(1):19-35. PubMed ID: 19594097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The 28th report on survey of the adverse reaction to radiopharmaceuticals (the 31st survey in 2005)].
    Kusakabe K; Arano Y; Okamura T; Kasagi K; Komatani A; Matsuda H; Maruno H; ; ;
    Kaku Igaku; 2007 Feb; 44(1):29-42. PubMed ID: 18240581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The 33rd report on survey of the adverse reaction to radiopharmaceuticals (the 36th Survey in 2010)].
    Matsuda H; Arano Y; Okazawa H; Okamura T; Mizumura S; Yokoyama K; ; ;
    Kaku Igaku; 2012 Feb; 49(1):1-14. PubMed ID: 22624452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The 38th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 41st Survey in 2015)].
    ; Matsuda H; Uehara T; Okazawa H; Mizumura S; Yokoyama K; Yoshimura M
    Kaku Igaku; 2017; 54(1):509-519. PubMed ID: 28804095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The eighth report on the survey of adverse reactions to radiopharmaceuticals (the 11th survey in 1985). Subcommittee on Radiopharmaceutical Safety Issues, Medical and Pharmaceutical Committee, Japan Radioisotope Association].
    Kaku Igaku; 1987 Apr; 24(4):497-503. PubMed ID: 3626151
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequency of adverse reactions to radiopharmaceuticals in Europe.
    Hesslewood SR; Keeling DH
    Eur J Nucl Med; 1997 Sep; 24(9):1179-82. PubMed ID: 9283115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.